Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL1600017	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs	Import Drug Application	2016-02-16	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2016-12-20	view
JXHL1600018	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs	Import Drug Application	2016-02-16	Novartis Pharma AG	Novartis Pharma Schweiz AG	Certificate Issued	2016-12-20	view
JXHL1600080	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs(2.3)	Import Drug Application	2016-08-15	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2017-03-21	view
JXHL1600081	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs(2.3)	Import Drug Application	2016-08-08	北京诺华制药有限公司	Beijing Novartis Pharma Co Ltd	Certificate Issued	2017-03-21	view
JXHL1700133	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs(2.3)	Import Drug Application	2017-08-10	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd	Certificate Issued	2018-01-11	view
JXHL1700134	QVM149	Glycopyrronium Bromide;Indacaterol;Mometasone Furoate	Active ingredient	Chemical Drugs(2.3)	Import Drug Application	2017-08-10	诺华（中国）生物医学研究有限公司	China Novartis Institutes For Biomedical Research Co Ltd	Certificate Issued	2018-01-11	view